Robert C Scheinfeld

December 05, 2011 | Legaltech News

Attorneys Robert C. Scheinfeld and Parker H. Bagley look at what confronts a company registering a new generic top-level domain name -- and the ensuing legal rights involved.

By Robert C. Scheinfeld and Parker H. Bagley

7 minute read

May 23, 2012 | New York Law Journal

In their Patent and Trademark Law column, Robert C. Scheinfeld, a partner at Baker Botts, and Parker H. Bagley, a partner at Goodwin Procter, address the interplay (or lack thereof) between coordinated or consolidated pretrial proceedings in multi-district litigation under 28 U.S.C. �1407 and the AIA, as well as the Federal Circuit's possible guidelines going forward to determine the circumstances under which separate cases may be consolidated for pretrial and trial proceedings.

By Robert C. Scheinfeld and Parker H. Bagley

10 minute read

January 23, 2013 | New York Law Journal

In their Patent and Trademark Law column, Baker Botts partner Robert C. Scheinfeld and Goodwin Procter partner Parker H. Bagley write: Many have speculated about the cause of the trend, including the movement into the patent field of contingent fee attorneys but, regardless, there are important principles to be gleaned from patent malpractice cases.

By Robert C. Scheinfeld and Parker H. Bagley

12 minute read

January 25, 2012 | New York Law Journal

In their Patent and Trademark Law column, Baker Botts partner Robert C. Scheinfeld and Goodwin Procter partner Parker H. Bagley ask readers their opinions on the pilot program meant to give specialist judges the opportunity to develop greater expertise in handling patent issues, and propose a method of expanding the proposal so that all district courts, even those that do not hear a large number of patent cases, can benefit.

By Robert C. Scheinfeld and Parker H. Bagley

15 minute read

March 27, 2013 | New York Law Journal

In their Patent and Trademark Law column, Robert C. Scheinfeld, a partner at Baker Botts, and Parker H. Bagley, a partner at Goodwin Procter, review a decision in which the U.S. Supreme Court found that the particular legal malpractice claim at issue did not "arise" under federal patent law and, indeed, state legal malpractice claims based on underlying patent matters will "rarely, if ever," arise under federal patent law.

By Robert C. Scheinfeld and Parker H. Bagley

6 minute read

July 25, 2012 | New York Law Journal

In their Patent and Trademark Law column, Robert C. Scheinfeld, a partner at Baker Botts, and Parker H. Bagley, a partner at Goodwin Procter, analyze the recent Federal Circuit holding that continued the trend in patent cases of taking previously considered factual issues away from juries - in this case, the question of whether a reasonable person would have considered there to be a high likelihood of infringement of a valid patent.

By Robert C. Scheinfeld and Parker H. Bagley

6 minute read

May 22, 2013 | New York Law Journal

In their Patent and Trademark Law column, Robert C. Scheinfeld, a partner at Baker Botts, and Parker H. Bagley, a partner at Goodwin Procter, write that the Federal Circuit does not have a specific rule relating to reassignment after remand and will look to the law of the circuit court in which the district court resides.

By Robert C. Scheinfeld and Parker H. Bagley

9 minute read

September 04, 1999 | Law.com

Two recent Supreme Court decisions have sharply curtailed the ability of IP owners to sue individual states for violations of property rights. In both cases, which involved the same parties, College Savings Bank and Florida Prepaid Postsecondary Education Expense Board, the majority held that states could assert sovereign immunity in suits brought for patent infringement or for false and misleading advertising. This paper examines the holdings -- and implications -- of this pair of watershed decisions.

By Robert C. Scheinfeld and Parker H. Bagley

14 minute read

September 24, 2008 | New York Law Journal

Robert C. Scheinfeld, a partner at Baker Botts, and Parker H. Bagley, a partner at Goodwin Procter, write that while KSR's full impact will not be known for a number of years, the increase in the Federal Circuit's invalidity decisions provides evidence that the circuit is applying the new, flexible obviousness regime, but is unwilling to completely depart from its pre-KSR obviousness jurisprudence.

By Robert C. Scheinfeld and Parker H. Bagley

8 minute read

September 26, 2001 | Law.com

President George W. Bush's Aug. 9, 2001 announcement that federal funds would support limited embryonic stem cell research sparked controversy, especially due to the ethical and moral considerations weighed against the potential benefits. Further controversy surrounds the patents for stem cells and the patentability of the resulting technology.

By Robert C. Scheinfeld and Parker H. Bagley

10 minute read